Up-regulation and Activation of Proteinase-Activated Receptor 2 in Early and Delayed Radiation Injury in the Rat Intestine: Influence of Biological Activators of Proteinase-Activated Receptor 2

Radiation Research

Volumn 160, Issue 5, 2003, Pages 524-535

  Wang, Junru ^a   Zheng, Huaien ^a   Hollenberg, Morley D ^b   Wijesuriya, Suranga J ^b   Ou, Xuemei ^a   Hauer Jensen, Martin ^a,c  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROGENESIS; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINAL FIBROSIS; IRRADIATION; MALE; MAST CELL; MITOGENESIS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; RAT; RECEPTOR UPREGULATION; SMALL INTESTINE;

ANIMALS; CELL LINE; ILEUM; INTESTINAL DISEASES; MALE; OCTREOTIDE; PANCREAS; RADIATION INJURIES, EXPERIMENTAL; RADIATION TOLERANCE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-2; TISSUE DISTRIBUTION; UP-REGULATION;

RICKETTSIA SP. PAR;

EID: 0347989194     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3080     Document Type: Article

References (65)

1. P. J. Eifel, C. Levenback, J. T Wharton and M. J. Oswald, Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 32, 1289-1300 (1995).
2. E. Yeoh, M. Horowitz, A. Russo, T. Muecke, T Robb, A. Maddox and B. Chatterton, Effect of pelvic irradiation on gastrointestinal function: A prospective longitudinal study. Am. J. Med. 95, 397-406 (1993).
3. P. Fransson and A. Widmark, Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma. Cancer 85, 678-688 (1999).
4. H. Zheng, J. Wang and M. Hauer-Jensen, Role of mast cells in early and delayed radiation injury in rat intestine. Radiat. Res. 153, 533-539 (2000).
5. J. Wang, H. Zheng, C-C. Sung and M. Hauer-Jensen, The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury, Int. J. Radiat. Oncol. Biol. Phys. 45, 1289-1296 (1999).
6. S. R. MacFarlane, M. J. Seatter, T. Kanke, G. D. Hunter and R. Plevin, Proteinase-activated receptors. Pharmacol. Rev. 53, 245-282 (2001).
7. M. Saifeddine, B. Al-Ani, C-H. Cheng, L. Wang and M. D. Hollenberg, Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br. J. Pharmacol. 118, 521-530 (1996).
8. W. Kong, K. McConalogue, L. M. Khitin, M. D. Hollenberg, D. G. Payan, S. K. Böhm and N. W. Bunnett, Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc. Natl. Acad. Sci. USA 94, 8884-8889 (1997).
9. B. Al-Ani, M. Saifeddine, A. Kawabata, B. Renaux, S. Mokashi and M. D. Hollenberg, Proteinase-activated receptor 2 (PAR2): Development of a ligand-binding assay correlating with activation of PAR2 by PAR1 and PAR2-derived peptide ligands. J. Pharmacol. Exp. Ther. 290, 753-760 (1999).
10. C. W. Langberg, T Sauer, J. B. Reitan and M. Hauer-Jensen, Tolerance of rat small intestine to localized single dose and fractionated irradiation. Acta Oncol. 31, 781-787 (1992).
11. C. W. Langberg, T Sauer, J. B. Reitan and M. Hauer-Jensen, Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncol. 35, 81-87 (1996).
12. J. Wang, H. Zheng and M. Hauer-Jensen, Influence of short-term octreotide administration on chronic tissue injury, transforming growth factor β (TGF-β) overexpression and collagen accumulation in irradiated rat intestine. J. Pharmacol. Exp. Ther. 297, 35-42 (2001).
13. M. Hauer-Jensen, L. Poulakos and J. W. Osborne, Effects of accelerated fractionation on radiation injury of the small intestine: A new rat model. Int. J. Radiat. Oncol. Biol. Phys. 14, 1205-1212 (1988).
14. C. W. Langberg, J. A. Waldron, M. L. Baker and M. Hauer-Jensen, Significance of overall treatment time for the development of radiation-induced intestinal complications. An experimental study in the rat. Cancer 73, 2663-2668 (1994).
15. K. K. Richter, C-C. Sung, C. W. Langberg and M. Hauer-Jensen, Association of transforming growth factor β (TGF-β) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy. Radiother. Oncol. 39, 201-302 (1996).
16. J. Wang, H. Zheng, C-C. Sung, K. K. Richter and M. Hauer-Jensen, Cellular sources of transforming growth factor β (TGF-β) isoforms in early and chronic radiation enteropathy. Am. J. Pathol. 153, 1531-1540 (1998).
17. H. Zheng, J. Wang, V. E. Koteliansky, P. J. Gotwals and M. Hauer-Jensen, Recombinant soluble transforming growth factor-β type II receptor ameliorates radiation enteropathy in the mouse. Gastroenterology 119, 1286-1296 (2000).
18. M. Hauer-Jensen, T. Sauer, F. Devik and K. Nygaard, Late changes following single dose roentgen irradiation of rat small intestine. Acta Radiol. Oncol. 22, 299-303 (1983).
19. B. R. Scott, C. W. Langberg and M. Hauer-Jensen, Models for estimating the risk of ulcers in the small intestine after localized single or fractionated irradiation. Br. J. Radiol. 68, 49-57 (1995).
20. A. J. Baddeley, H. J. G. Gundersen and L. M. Cruz-Orive, Estimation of surface area from vertical sections. J. Microsc. 142, 259-276 (1986).
21. Y. Niwa, T Kasugai, K. Ohno, M. Morimoto, M. Yamazaki, K. Dohmae, Y. Nishimune, K. Kondo and Y. Kitamura, Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. Blood 78, 1936-1941 (1991).
22. M. Morimoto, T Kasugai, H. Tei, T. Jippo-Kanemoto, Y. Kanakura and Y. Kitamura, Age-dependent amelioration of hypoplastic anemia in Ws/Ws rats with a small deletion at the kinase domain of c-kit. Blood 82, 3315-3320 (1993).
23. M. Hauer-Jensen, T Sauer, T. Berstad and K. Nygaard, Influence of pancreatic secretion on late radiation enteropathy in the rat. Acta Radiol. Oncol. 24, 555-560 (1985).
24. L. Morgenstern and N. Hiatt, Injurious effect of pancreatic secretions on postradiation enteropathy. Gastroenterology 53, 923-929 (1967).
25. S. Rachootin, S. Shapiro, T Yamakawa, L. Goldman, S. Patin and L. Morgenstern, Potent anti-protease from Ascaris lumbricoides: Efficacy in amelioration of post-radiation enteropathy. Gastroenterology 62, 796 (1972).
26. N. Vergnolle, J. L. Wallace, N. W. Bunnett and M. D. Hollenberg, Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol. Sci. 22, 146-152 (2001).
27. S. Nystedt, K. Emilsson, C. Wahlestedt and J. Sundelin, Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. USA 91, 9200-9202 (1994).
28. H. Mirza, V. A. Schmidt, C. K. Derian, J. Jesty and W. F. Bahou, Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell α- or β-tryptases. Blood 90, 3914-3922 (1997).
29. M. Molino, E. S. Barnathan, R. Numerof, J. Clark, M. Dreyer, A. Cumashi, J. A. Hoxie, N. Schechter, M. Woolkalis and L. F. Brass, Interactions of mast cell tryptase with thrombin receptors and PAR2. J. Biol. Chem. 272, 4043-4049 (1997).
30. S. K. Bohm, W. Kong, D. Bromme, S. P. Smeekens, D. C. Anderson, A. Connolly, M. Kahn, N. A. Nelken, S. R. Coughlin and N. W. Bunnett, Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem. J. 314, 1009-1016 (1996).
31. M. R. d'Andrea, C. K. Derian, D. Leturcq, S. M. Baker, A. Brunmark, P. Ling, A. L. Darrow, R. J. Santulli, L. F. Brass and P. Andrade-Gordon, Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J. Histochem. Cytochem. 46, 157-164 (1998).
32. C. U. Corvera, O. Dery, K. McConalogue, P. Gamp, M. Thoma, B. Al-Ani, G. H. Caughey, M. D. Hollenberg and N. W. Bunnett, Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J. Physiol. 517, 741-756 (1999).
33. B. T. Green, N. W. Bunnett, A. Kulkarni-Narla, M. Steinhoff and D. R. Brown, Intestinal type 2 proteinase-activated receptors: Expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport. J. Pharmacol. Exp. Ther. 295, 410-416 (2001).
34. M. Mall, T. Gonska, J. Thomas, S. Hirtz, R. Schreiber and K. Kunzelmann, Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am. J. Physiol. 282, G200-G210 (2002).
35. + absorption in the mouse distal colon. J. Physiol. 539, 209-222 (2002).
36. A. M. Coelho, N. Vergnolle, B. Guiard, J. Fioramonti and L. Bueno, Proteinases and proteinase-activated receptor 2: A possible role to promote visceral hyperalgesia in rats. Gastroenterology 122, 1035-1047 (2002).
37. D. R. Linden, B. P. Manning, N. W. Bunnett and G. W. Mawe, Agonists of proteinase-activated receptor 2 excite guinea pig ileal myenteric neurons. Eur. J. Pharmacol. 431, 311-314 (2001).
38. S. Fiorucci, A. Mencarelli, B. Palazzetti, E. Distrutti, N. Vergnolle, M. D. Hollenberg, J. L. Wallace, A. Morelli and G. Cirino, Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc. Natl. Acad. Sci. USA 98, 13936-13941 (2001).
39. S. Miike, A. S. McWilliam and H. Kita, Trypsin induces activation and inflammatory mediator release from human eosinophils through proteinase-activated receptor-2. J. Immunol. 167, 6615-6622 (2001).
40. N. Cenac, A. M. Coelho, C. Nguyen, S. J. Compton, P. Andrade-Gordon, W. K. MacNaughton, J. L. Wallace, M. D. Hollenberg, N. W. Bunnett and N. Vergnolle, Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor 2. Am. J. Pathol. 161, 1903-1913 (2002).
41. J. S. Thompson, B. L. Nguyen and R. F. Harty, Somatostatin analogue inhibits intestinal regeneration. Arch. Surg. 128, 385-389 (1993).
42. N. Vergnolle, Proteinase-activated receptor-2-activating peptide induce leukocyte rolling, adhesion, and extravasation in vivo. J. Immunol. 163, 5064-5066 (1999).
43. N. Vergnolle, M. D. Hollenberg, K. A. Sharkey and J. L. Wallace, Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br. J. Pharmacol. 127, 1083-1090 (1999).
44. M. Steinhoff, N. Vergnolle, S. H. Young, M. Tognetto, S. Amadesi, H. S. Ennes, M. Trevisani, M. D. Hollenberg, J. L. Wallace and N. W. Bunnett, Agonist of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6, 151-158 (2000).
45. J. R. Lindner, M. L. Kahn, S. R. Coughlin, G. R. Sambrano, E. Schauble, D. Bernstein, D. Foy, A. Hafezi-Moghadam and K. Ley, Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J. Immunol. 165, 6504-6510 (2000).
46. S. Nystedt, V. Ramakrishnan and J. Sundelin, The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. J. Biol. Chem. 271, 14910-14915 (1996).
47. N. Vergnolle, W. K. MacNaughton, B. Al-Ani, M. Saifeddine, J. L. Wallace and M. D. Hollenberg, Proteinase-activated receptor 2 (PAR2)-activating peptides: Identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc. Natl. Acad. Sci. USA 95, 7766-7771 (1998).
48. C. U. Corvera, O. Déry, K. McConalogue, L. M. Khitin, G. H. Caughey, D. G. Payan and N. W. Bunnett, Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J. Clin. Invest. 100, 1383-1393 (1997).
49. A. Kawabata, R. Kuroda, H. Nishikawa and K. Kawai, Modulation by protease-activated receptors of the rat duodenal motility in vitro: Possible mechanisms underlying the evoked contraction and relaxation. Br. J. Pharmacol. 126, 1856-1862 (1999).
50. H. Mirza, V. Yatsula and W. F. Bahou, The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. J. Clin. Invest. 97, 1705-1714 (1996).
51. F. Bono, I. Lamarche and J-M. Herbert, Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2). Biochem. Biophys. Res. Commun. 241, 762-764 (1998).
52. I. A. Akers, M. Parsons, M. R. Hill, M. D. Hollenberg, S. Sanjar, G. J. Laurent and R. J. McAnulty, Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am. J. Physiol. 278, L193-L201 (2000).
53. K. Emilsson, C. Wahlestedt, M. K. Sun, S. Nystedt, C. Owman and J. Sundelin, Vascular effects of proteinase-activated receptor 2 agonist peptide. J. Vasc. Res. 34, 267-272 (1997).
54. B. P. Damiano, W. M. Cheung, R. J. Santulli, W. P. Fung-Leung, K. Ngo, R. D. Ye, A. L. Darrow, C. K. Derian, L. De Garavilla and P. Andrade-Gordon, Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther. 288, 671-678 (1999).
55. A. Kawabata, R. Kuroda, T Minami, K. Kataoka and M. Taneda, Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol. 125, 419-422 (1998).
56. L. Hou, S. Kapas, A. T. Cruchley, M. G. Macey, P. Harriott, C. Chinni, S. R. Stone and G. L. Howells, Immunolocalization of protease-activated receptor-2 in skin: Receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 94, 356-362 (1998).
57. A. K. Alm, E. Norstrom, J. Sundelin and S. Nystedt, Stimulation of proteinase activated receptor-2 causes endothelial cells to promote blood coagulation in vitro. Thromb. Haemost. 81, 984-988 (1999).
58. E Langer, C. Morys-Wortmann, B. Kusters and J. Storck, Endothelial protease-activated receptor-2 induces tissue factor expression and von Willebrand factor release. Br. J. Haematol. 105, 542-550 (1999).
59. J. Storck, B. Kusters, M. Vahland, C. Morys-Wortmann and E. R. Zimmermann, Trypsin induced von Willebrand factor release from human endothelial cells is mediated by PAR-2 activation. Thromb. Res. 84, 463-473 (1996).
60. E Bono, P. Schaeffer, J-P. Herault, C. Michaux, A. L. Nestor, J. C. Guillemot and J-M. Herbert, Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2. Arterioscler. Thromb. Vasc. Biol. 20, E107-E112 (2000).
61. E. Camerer, W. Huang and S. R. Coughlin, Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. USA 97, 5255-5260 (2000).
62. H. Vliagoftis, A. D. Befus, M. D. Hollenberg and R. Moqbel, Airway epithelial cells release eosinophil survival-promoting factors (GMCSF) after stimulation of proteinase-activated receptor 2. J. Allergy Clin. Immunol. 107, 679-685 (2001).
63. H. Vliagoftis, A. Schwingshackl, C. D. Milne, M. Duszyk, M. D. Hollenberg, J. L. Wallace, A. D. Befus and R. Moqbel, Proteinase-activated receptor-2 mediated matrix metalloproteinase-9 release from airway epithelial cells. J. Allergy Clin. Immunol. 106, 537-545 (2000).
64. N. Hovdenak, L. F. Fajardo and M. Hauer-Jensen, Acute radiation proctitis: A sequential clinicopathologic study during pelvic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 48, 1111-1117 (2000).
65. N. Hovdenak, J. Wang, C-C. Sung, T. Kelly, L. F. Fajardo and M. Hauer-Jensen, Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 53, 919-927 (2002).